Research graph
References from Inebilizumab Monotherapy in Relapsing IgG4-Related Tubulointerstitial Nephritis. Local targets link to admitted publications; unresolved targets remain external evidence.
Incidence, prevalence and mortality of IgG4-related disease in the USA: a claims-based analysis of commercially insured adults
10.1136/ard-2023-223950 · 2023 · External reference
IgG4-related kidney disease
10.2215/cjn.0000000000000235 · 2023 · External reference
IgG4-related disease: a clinical perspective
10.1093/rheumatology/kez667 · 2020 · External reference
IgG4-related kidney disease and retroperitoneal fibrosis: an update
10.1080/14397595.2018.1554321 · 2019 · External reference
Inebilizumab for treatment of IgG4-related disease
10.1056/nejmoa2409712 · 2025 · External reference
